KE2975A - Benzoxazole derivatives - Google Patents

Benzoxazole derivatives

Info

Publication number
KE2975A
KE2975A KE2975A KE297579A KE2975A KE 2975 A KE2975 A KE 2975A KE 2975 A KE2975 A KE 2975A KE 297579 A KE297579 A KE 297579A KE 2975 A KE2975 A KE 2975A
Authority
KE
Kenya
Prior art keywords
benzoxazole derivatives
derivatives
benzoxazole
cyclising
pyretic
Prior art date
Application number
KE2975A
Other languages
English (en)
Inventor
D Evans
T A Hicks
D W Dunwell
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of KE2975A publication Critical patent/KE2975A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
KE2975A 1972-05-18 1979-07-03 Benzoxazole derivatives KE2975A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2340972A GB1435721A (en) 1972-05-18 1972-05-18 Benzoxazole derivatives

Publications (1)

Publication Number Publication Date
KE2975A true KE2975A (en) 1979-07-20

Family

ID=10195157

Family Applications (1)

Application Number Title Priority Date Filing Date
KE2975A KE2975A (en) 1972-05-18 1979-07-03 Benzoxazole derivatives

Country Status (31)

Country Link
US (1) US3912748A (pm)
JP (6) JPS5912672B2 (pm)
KR (1) KR780000234B1 (pm)
AR (4) AR230991A1 (pm)
AT (1) AT333752B (pm)
BE (1) BE799790A (pm)
BG (1) BG21408A3 (pm)
CA (1) CA1029019A (pm)
CH (5) CH587834A5 (pm)
CS (1) CS200455B2 (pm)
CY (1) CY1016A (pm)
DD (1) DD105229A5 (pm)
DE (1) DE2324443A1 (pm)
DK (1) DK140340B (pm)
ES (1) ES414863A1 (pm)
FR (2) FR2184966B1 (pm)
GB (1) GB1435721A (pm)
HK (1) HK72579A (pm)
HU (1) HU167933B (pm)
IE (2) IE37564B1 (pm)
IL (2) IL42102A (pm)
KE (1) KE2975A (pm)
MY (1) MY8000063A (pm)
NL (1) NL170145C (pm)
PH (3) PH9685A (pm)
PL (3) PL89247B1 (pm)
RO (2) RO66800A (pm)
SE (3) SE386174B (pm)
SU (3) SU574157A3 (pm)
YU (3) YU130473A (pm)
ZA (1) ZA732791B (pm)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1495488A (en) * 1976-06-23 1977-12-21 Ippco Int Pharma Patents Co Es Optically active 2-(2-phenyl-5-benzoxazolyl)propionic acids
US4087437A (en) * 1976-09-07 1978-05-02 Eli Lilly And Company 2-Phenyl-5-benzoxazolylalkanoic acid purification process
GB1590587A (en) * 1977-06-28 1981-06-03 Lilly Industries Ltd Benoxaprofen
IT1099589B (it) * 1978-08-04 1985-09-18 Ravizza Spa Processo per la preparazione di derivati dell'acido benzoxazolil propionico
CA1125768A (en) * 1978-10-31 1982-06-15 Hoffmann-La Roche Limited Benzoxazole derivatives
GR75153B (pm) * 1981-03-27 1984-07-13 Lilly Co Eli
IT1157295B (it) * 1982-07-19 1987-02-11 Ravizza Spa Processo perfezionato per la preparazione di derivati dell'acido benzoxazolil propionico
DE3413875A1 (de) * 1984-04-12 1985-10-17 Ludwig Heumann & Co GmbH, 8500 Nürnberg Benzothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
IT1177017B (it) * 1984-10-22 1987-08-26 Ravizza Spa Processo per la preparazione dell'acido 2(4-flurofenil)alfa-metil-5-benzox azoloacetico
US4873259A (en) * 1987-06-10 1989-10-10 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
US4822809A (en) * 1987-11-13 1989-04-18 Abbott Laboratories Benzazole lipoxygenase inhibiting compounds
IT1233836B (it) * 1988-01-13 1992-04-21 Euroresearch Srl Sali idrosolubili dell'acido (+)2-(4 fluorofenil)-alfa-metil-5 benzoxazolo acetato.
UA83620C2 (ru) * 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
AU2003283597A1 (en) * 2002-11-16 2004-06-15 Oxford Glycosciences (Uk) Ltd Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors
JP4790594B2 (ja) * 2003-02-25 2011-10-12 トポターゲット ユーケー リミテッド Ｈｄａｃインヒビターとしての、二環式ヘテロアリール基を含むヒドロキサム酸化合物
ME01868B (me) * 2004-12-15 2010-10-31 Dompe Pha R Ma Spa Res & Mfg Derivati 2-arilpropionske kiseline i farmaceutske smeše, koje ih sadrže
CA2609659C (en) 2005-05-26 2014-01-28 Neuron Systems, Inc. Azanaphthalenes, compositions and methods for treating retinal disease
JP5369854B2 (ja) 2008-04-21 2013-12-18 住友化学株式会社 有害節足動物防除組成物および縮合複素環化合物
WO2011072141A1 (en) 2009-12-11 2011-06-16 Neuron Systems, Inc. Compositions and methods for the treatment of macular degeneration
RU2018145691A (ru) 2013-01-23 2019-04-01 Альдейра Терапьютикс, Инк. Заболевания, связанные с токсичным альдегидом, и их лечение
MX2015009444A (es) 2013-01-25 2016-04-15 Aldeyra Therapeutics Inc Trampas novedosas en el tratamiento de la degeneracion macular.
JPWO2016021706A1 (ja) * 2014-08-08 2017-05-25 カズマパートナーズ株式会社 縮合複素環化合物
US10550085B2 (en) 2015-08-21 2020-02-04 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof
AU2017264697A1 (en) 2016-05-09 2018-11-22 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
WO2018170476A1 (en) 2017-03-16 2018-09-20 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
AU2018348174A1 (en) 2017-10-10 2020-04-23 Aldeyra Therapeutics, Inc. Treatment of inflammatory disorders
US12006298B2 (en) 2018-08-06 2024-06-11 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CA3113462A1 (en) 2018-09-25 2020-04-02 Aldeyra Therapeutics, Inc. Formulations of reproxalap for the treatment of dry eye disease
JP7706758B2 (ja) 2019-03-26 2025-07-14 アルデイラ セラピューティクス， インコーポレイテッド 眼科用製剤およびその使用
WO2020223717A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
CA3137301A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CA3175856A1 (en) 2020-05-13 2021-11-18 Todd Brady Pharmaceutical formulations and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70860A (pm) *
NL285932A (pm) * 1961-11-27
CH516339A (de) * 1969-03-03 1971-12-15 Ciba Geigy Ag Verwendung von Azolverbindungen als Antioxydantien
DE2118315C3 (de) * 1970-04-20 1975-04-03 Sumitomo Chemical Co., Ltd., Osaka (Japan) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
IL37633A (en) * 1970-09-10 1975-08-31 Merck & Co Inc 2-(4-(2-benzoxazolyl)phenyl)alkanoic acid derivatives
DE2115926C3 (de) * 1971-04-01 1978-05-03 C.H. Boehringer Sohn, 6507 Ingelheim 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
GB1491863A (en) * 1973-10-23 1977-11-16 Lilly Industries Ltd 2,5-or 2,6-disubstituted benzoxazoles
GB1590587A (en) * 1977-06-28 1981-06-03 Lilly Industries Ltd Benoxaprofen

Also Published As

Publication number Publication date
YU117079A (en) 1981-08-31
ATA432573A (de) 1976-04-15
HU167933B (pm) 1976-01-28
SE386174B (sv) 1976-08-02
SU574157A3 (ru) 1977-09-25
AR205021A1 (es) 1976-03-31
FR2184966B1 (pm) 1979-01-12
AR212010A1 (es) 1978-04-28
PL89247B1 (pm) 1976-11-30
PH9685A (en) 1976-02-10
NL7307018A (pm) 1973-11-20
AR230991A1 (es) 1984-08-31
DD105229A5 (pm) 1974-04-12
SU582762A3 (ru) 1977-11-30
AR207857A1 (es) 1976-11-08
SE7710602L (sv) 1977-09-21
AT333752B (de) 1976-12-10
JPS56167645A (en) 1981-12-23
CS200455B2 (en) 1980-09-15
SE434399B (sv) 1984-07-23
PL92565B1 (pm) 1977-04-30
NL170145C (nl) 1982-10-01
MY8000063A (en) 1980-12-31
ES414863A1 (es) 1976-02-01
KR780000234B1 (en) 1978-07-01
JPS56167675A (en) 1981-12-23
PL94208B1 (pm) 1977-07-30
IE37563B1 (en) 1977-08-17
SU580837A3 (ru) 1977-11-15
IL42102A0 (en) 1973-06-29
CH592071A5 (pm) 1977-10-14
PH10704A (en) 1977-08-24
IL42102A (en) 1977-07-31
JPS4954363A (pm) 1974-05-27
HK72579A (en) 1979-10-19
IE37564B1 (en) 1977-08-17
DK140340C (pm) 1979-12-31
PH11718A (en) 1978-05-30
GB1435721A (en) 1976-05-12
YU36298B (en) 1982-06-18
ZA732791B (en) 1974-12-24
CA1029019A (en) 1978-04-04
CH587834A5 (pm) 1977-05-13
JPS56167673A (en) 1981-12-23
RO66800A (ro) 1982-03-24
IE37564L (en) 1973-11-18
CH595361A5 (pm) 1978-02-15
CH595362A5 (pm) 1978-02-15
RO66278A (ro) 1981-06-26
JPS56167674A (en) 1981-12-23
SE435838B (sv) 1984-10-22
BE799790A (fr) 1973-11-19
JPS5912672B2 (ja) 1984-03-24
JPS59161346A (ja) 1984-09-12
DE2324443A1 (de) 1973-11-29
YU130473A (en) 1981-08-31
BG21408A3 (bg) 1976-05-20
IL48711A0 (en) 1976-02-29
AU5590773A (en) 1974-11-21
NL170145B (nl) 1982-05-03
IE37563L (en) 1973-11-18
US3912748A (en) 1975-10-14
JPS5929185B2 (ja) 1984-07-18
JPS6021976B2 (ja) 1985-05-30
CH594643A5 (pm) 1978-01-13
FR2284592B1 (pm) 1979-01-05
FR2184966A1 (pm) 1973-12-28
FR2284592A1 (fr) 1976-04-09
YU117179A (en) 1981-08-31
SE7509387L (sv) 1975-08-22
DK140340B (da) 1979-08-06
CY1016A (en) 1979-11-23

Similar Documents

Publication Publication Date Title
FR2284592B1 (pm)
ATA1114372A (de) Tellerformige verbundanode als drehanode fur rontgenrohren
ES412813A1 (es) Un procedimiento de preparacion de derivados de 1,2-benzoi-soxazol 3-sustituidos.
OA04406A (fr) Procédé de préparation de dérivés de 14-hydroxy-morphinane.
OA04555A (fr) Procédé de préparation de dérivés de benzofuranne.
OA04511A (fr) Procédé de préparation de 3-hydroxycéphalosporines.
OA04510A (fr) Procédé de préparation d'éthers d'&-aminoacylcéphalosporine.
ES432334A1 (es) Procedimiento de obtencion de derivados 1-amido alquil-4- sulfonil-piperazina.
OA04655A (fr) Procédé de production de dérivés 3-thiolés d'acides 7-acylamidocéphalosporanique.
ES412453A1 (es) Un procedimiento para la preparacion de un compuesto de ce-falosporina.
ES414645A1 (es) Un procedimiento para convertir un penilinsufoxido en una desacetoxi-cefalosporina.
OA04432A (fr) Procédé de préparation de 3-amino-pyrazolones-(5).
BG29134A3 (en) Method of obtaining of 4- bromphenylcarbamide derivatives
ES403313A1 (es) Procedimiento de obtencion de un nuevo derivado del acido 3,4,5 trimetoxibenzoico y sus sales.
CA910911A (en) Process for the manufacture of oxazole derivatives
GB1122135A (en) A new derivative of 4-hydroxy-coumarin, process for preparing same, and applications thereof
JPS51126488A (en) Numerical control system